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Nonpharmacological therapy is being evaluated for the prevention of atrial ﬁbrillation
(AF). Pacing has been proposed as a one of the option to prevent AF. In patients with
bradycardia and requiring pacemaker, physiological pacing such as dual chamber pacing or
atrial pacing has an advantage against ventricular pacing in prevention AF. Pacing from novel
site like the dual-site atrium, biatrial, Bachman, and low sepatl pacing may reduce AF burden
and new anti-AF pacemakers with atrial prevention algorithm may decrease AF further.
However, selecting the appropriate patients and adopting tailored-therapy for individual
patient is likely to remain one of the diﬃculties in achieving an advantage. This review
discusses the current status of pacing therapy for the prevention of AF. It also discusses the
some of merits and limitations of pacing therapy for the treatment of AF.
(J Arrhythmia 2005; 21: 438–449)
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Introduction
Atrial ﬁbrillation (AF) is the most common atrial
arrhythmia, often resulting in cerebral embolism and
a deterioration of hemodynamics. According to the
Framingham study,1) AF patients had a nearly two-
fold increase in all-cause mortality and a ﬁve-fold
risk for a stroke. The incidence of AF is 0.5% in the
ﬁfties age group and rapidly increases to 8.8%
associated with aging in the eighties.1) The manage-
ment of AF has been started with antiarrhythmic
drugs in combination with anticoagulant drugs as the
ﬁrst-line therapy but it is still unsatisfactory. Strat-
egies to treat AF include rate control or rhythm
control such as maintaining of sinus rhythm obtained
from pharmacologic therapy, pacing therapy and
catheter ablation intervention. AF has been consid-
ered as a benign arrythmia for many years. If it is
true, the rate control is an acceptable therapy for
management of patients with recurrent AF2–5) and
anticoagulant therapy should not be discontinued in
high-risk patients, even though sinus rhythm has
been restored and maintained. Besides, the compo-
nents of heart rate such as resting rate, activity rate,
night-time rate and chronotropic competence need to
be further investigated. On the other hand, recent
studies have shown that AF increased the risk for
cardiovascular morbidity and mortality.2,4,6,7) There-
fore attempts aiming to maintain sinus rhythm have
been performed in recent years. In the last two
decades the number of nonpharmacologic therapy
for AF has markedly increased. With advances in
medical engineering, a variety of devices have been
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applied to arrhythmia therapy. Radiofrequency cath-
eter ablation is highly eﬀective for the treatment of
many forms of supraventricular tachycardia and
implantable cardioverter for the life-threatening
ventricular tachycardia. However, there is no con-
sensus and recommendable devices regarding opti-
mal management of AF. The pacemaker therapy for
AF has been preliminary performed for the purpose
of improving bradycardia and improving the hemo-
dynamics in patients with congestive heart failure.
Although pacemaker therapy for prevention of
paroxysmal AF now has not been the established
therapeutic method yet, its eﬀectiveness is suggested
and noticed in the results of the study on several
patients.8–10) This paper reviews recent and on-going
developments in pacing management of AF.
Factors involved in the onset of atrial ﬁbril-
lation
A variety of abnormalities of atrial electrophysi-
ology have been found in patients susceptible to AF,
including a spatially heterogeneous shortening of
atrial refractoriness, conduction delay,11–13) abnor-
mal adaptation of refractoriness to rate,14) and a
dispersion of atrial refractoriness. It is known that
the presence of dispersion of atrial refractoriness
beyond the physiological range and slow conduction
is likely to induce and continue AF.15,16) The
structural and functional changes of the atrium
increase the dispersion of atrial refractoriness and
reduce the conduction velocity. Where atrial sub-
strate exists, episodes of AF are thought to be
triggered by abnormal timing cycle such as the short-
long sequence and the atrial premature beat (Fig-
ure 1). Also it is known that the autonomic nerve is
deeply concerned with the onset of AF and that AF
occurs after stimulation of the parasympathetic nerve
of atrial wall and administration of acetylcholine.
Bradycardia is involved in the onset of this type of
AF, which is observed at night and at rest. This is
considered to be caused by shortening of the
refractory period after stimulation of the parasym-
pathetic nerve.17) In the sympathetic nerve-induced
AF, it is induced by marked exercise or stress, on the
other hand, the attack occurs during the daytime,
which is obviously diﬀerent from the parasympa-
thetic nerve-induced one.18) Additionally, in case of
symptomatic nerve-induced AF, there are many
patients with underlying cardiac disease. The trig-
gering mechanism involved with the sympathetic
nerve-induced AF is unclear. However, basic studies
have shown the etiologies such as the increased heart
rate, the occurrence of atrial premature contraction
due to the direct eﬀect of adrenaline on the
myocardium, the increasing automaticity, and the
increased inappropriate contractility. Basically, the
onset mechanism of AF has been elucidated well, but
unfortunately the clinical study has not been con-
ducted well.
Analysis the onset mechanisms of atrial
ﬁbrillation stored in the pacemakers
It is believed that the memory function in dual
chamber pacemaker oﬀer distinct diagnostic advan-
tages in the long term follow up of patients.19) The
data obtained from 24-h Holter ECG might be
reliable to evaluate the prevalence of paroxysmal
AF, but the storage period is too short. The only
reliable way to diagnose paroxysmal AF is to
continuously monitor the patient’s intrinsic cardiac
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Figure 1 Factor involved in the onset of
atrial ﬁbrillation.
Atrial premature contraction and abnormal
rhythm may trigger the onset of atrial ﬁbrilla-
tion.
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rhythm. Recently, a multicenter collaborative study
(AF Therapy) to examine the mechanism of the
onset of AF is in progress in the patients with drug-
resistant paroxysmal AF.20–22) According to the
results, among patients with arrhythmia immediately
before the onset of atrial ﬁbrillation, sinus brady-
cardia was most frequently observed (55%), then
multiple atrial premature contraction (18%), and the
onset of bradycardia derived from sinus rhythm
secondary to atrial premature contraction (15%), and
the remaining patients showed a sudden drop in heart
rate due to sequence abnormality and hypersensitive
carotid sinus syndrome. From these results, the onset
of AF is classiﬁed into four group; the contribution
of atrial premature contraction (Figure 2), the pause
after atrial premature contraction, the one relating to
exercise, and the one on which identiﬁcation is
diﬃcult.
Mechanism of prevention of atrial ﬁbrillation
by pacing
It is well known that when the atrium is regularly
paced in patients with sinus dysfunction, the in-
cidence of AF may decrease. The long pause, atrial
premature contraction and sinus bradycardia may
trigger AF. It is therefore important to keep regular
pacing on the atrium. If there is a structural
dispersion of refractoriness in the atrium, it is
expected that pacing prevent unidirectional conduc-
tion block of ectopic excitation by the synchroniza-
tion of depolarization and the preliminary activation
of the site of slow conduction. If a conduction
disturbance is already present in the atrium, the site
of pacing may be important, and multi-site pacing
may be useful.23) With respect to the functional
factor aﬀecting the atrial substrate, there is a
possibility that the hemodynamics, atrial ischemia
and hyper-stretch of atrial wall may be improved by
selecting DDD pacing instead of the VVI pacing
because of coordinative pacing on the atrium and
ventricle. Additionally, it is considered that the
pacing therapy prevents sympathetic nerve- or para-
sympathetic nerve-induced AF by keeping the
balance between the sympathetic nerve and the
parasympathetic nerve.24)
Preventing pacing for atrial ﬁbrillation
1) Pacing mode selection
Retrospective study have suggest that physiolog-
ical pacing has been oﬀered substantial beneﬁt in
reducing the incidence of persistent AF and the
prevalence of paroxysmal AF, as compared with
ventricular pacing.25–27) In our series, the long-term
evaluation of the development of persistent AF and
recurrence of paroxysmal AF were studied in 70
patients with a history of AF before pacemaker
implantation. In a mean follow-up of 8 years, the
incidence of chronic AF was 78% in the patients
undergoing VVI pacing compared with 45% in DDD
pacing and recurrence rate of paroxysmal AF was
93% in VVI pacing and 58% in DDD pacing.28)
Despite all the studies suggesting a disadvantage of
VVI mode, a few randomized, controlled study has
been performed.27–29) Although the Canadian Trial of
Physiologic Pacing (CTOPP)30) did not show beneﬁt
of physiologic pacing on overall mortality, CTOPP
reported an 18% reduction (6.6% annual rate with
ventricular pacing vs 5.3% with physiological pac-
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Figure 2 Rate proﬁle diagram.
In this case, atrial ﬁbrillation was started followed by single PAC.
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ing) in the risk of all AF episodes in patients with
physiologic pacing compared with those in the
ventricular pacing. This beneﬁcial AF reducing
eﬀect have been appeared at approximately six
months and continue over 4 years after pacemaker
implantation.31) In spite of lacking the reduction of
mortality in physiological pacing, subgroup analysis
showed beneﬁcial eﬀect on combined end point of
stroke or cardiovascular death, as well as cardiovas-
cular-death and total mortality in pacemaker depend-
ent group but not in non-pacemaker dependent
group.32) In addition, this study reported that un-
paced heart rate at ﬁrst follow-up has an important
inﬂuence on cardiovascular death and total mortality.
Ongoing pacing trial like as the Danish Multicenter
Randomized Study (DANPACE)33) and the United
Kingdom Pacing and Clinical Event Trial (UK-
Pace)34) may provide prospective data on the relation
between underlying heart rate and pacing mode
selection in view point of mortality. However, the
issue on indication for AF patients without brady-
cardia is still remained. One study, the Atrial Pacing
Periablation of Paroxysmal Atrial Fibrillation (PA3)
reported that atrial rate-adaptive pacing (DDIR) dose
not prevent paroxysmal atrial ﬁbrillation (PAF) in
patients with drug-resistant PAF without sympto-
matic bradycardia. Several limitations of the PA3
studies need to be addressed. There was no total AF
burden were used to verify AF recurrence, time to
ﬁrst recurrence of PAF is not a random event, and
pacing percentage in the DDIR group was only
67%.35,36)
One of the main disadvantages of conventional
DDD pacing is its ability to track atrial events. For
the appropriate DDD pacing, high sensitivity pro-
gramming is needed to detect all intrinsic P waves
and sustained programming upper rate pacing were
easily induced by these condition during the atrial
arrhythmia. Automatic mode switching is one of the
mechanisms in some DDDR pacemakers to prevent
the inappropriate high rate pacing. When the
arrhythmia are detect as nonphysiologic by the
pacemaker, the pacing mode automatically switches
from the DDDR to DDIR or VVIR pacing mode.
This algorithm might be released rapid irregular
response to ventricular stimulation37,38) but dose not
prevent paroxysmal atrial ﬁbrillation.
2) Eﬀect of atrial pacing site
There is much current interest in alternative-site
and dual-site atrial pacing for the prevention of atrial
ﬁbrillation. The prevention of AF was usually
attempted with single site atrial pacing,39–49) origi-
nally from right atrial appendage, recently from
other site like the coronary sinus or high and low
interatrial septum.41) More recently, multisite atrial
pacing has been proposed. This method includes
either dual-site pacing with which the high and low
positions in the atrium simultaneously paced or bi-
atrial pacing with which the right and left atria are
simultaneously paced. If there is a conduction
disturbance in the atrium, the prolonged P-wave
duration is easily recognized on surface electro-
cardiograms. It is impossible to reduce the P-wave
duration suﬃciently by single-site pacing from the
right atrium or the coronary sinus.42) However, it is
considered to be possible to reduce the P-wave
duration by dual-site pacing43) or by bi-atrial
pacing.44) Reduction of the P-wave duration results
in an improvement of conduction disturbance in the
Figure 3 An example of bi-atrial pacing.
A coronary sinus lead was inserted into the great cardiac vein to pace the left atrium. The pacemaker used was
Talent DR of Ela, Inc.
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atrium, and as a result, recurrence of paroxysmal
atrial ﬁbrillation is signiﬁcantly inhibited.45)
3) Multi-site pacing (bi-atrial pacing) (Figure 3)
It is known that atrial arrhythmia is observed in
patients with intraatrial conduction delay accompa-
nying retrograde conduction in the left atrium.46)
Daubert et al. reported that atrial arrhythmia could
be inhibited by performing the bi-atrial pacing on
such patients.47) It is considered that two factors such
as the dispersion of refractoriness and anisotropic
conduction are essential for persistence of atrial
arrhythmia,48) and bi-atrial pacing improves these
two factors. Additionally, in recent time, improve-
ment of slow conduction in the region of right
posterior interatrial septum is considered an impor-
tant factor.49) Judging from these ﬁndings, bi-atrial
pacing is indicated for the patients with a wide P-
wave showing delayed intraatrial conduction or
positive and negative bidirectionality. In order to
perform bi-atrial pacing, it is necessary to pace the
left atrium with a lead inserted into the coronary
sinus. However, there remains the procedural prob-
lem and an issue whether stable implantation can be
achieved chronically. Although various leads for the
coronary sinus have been developed, we are not fully
satisﬁed with them. If a DDD pacemaker is selected
for pacing, the model which oﬀers a short AV delay
is required and if ventricular pacing is required, a Y-
connector has to be used on atrial port. Recently, a
DDTA pacemaker to detect the intrinsic P-wave and
to pace the right and left atria simultaneously was
developed and noticed. Authors also have an
experience with bi-atrial pacing using this pace-
maker (Figure 3). Because this patient was diagnosed
as sinus dysfunction and underwent implantation of a
DDD pacemaker but frequently developed sympto-
matic paroxysmal atrial ﬁbrillation and showed a
resistant to drug therapy, a new pacemaker was
implanted after obtaining the patient’s consent.
Fortunately, paroxysmal atrial ﬁbrillation is com-
pletely inhibited over 5 years by the bi-atrial pacing
after changing the pacemaker.
4) Multi-site pacing (dual-site pacing) (Figure 4)
Saksena et al. consider that, although bi-atrial
pacing is indicated for patients with conduction
disturbance of the right and left atria among patients
with paroxysmal atrial ﬁbrillation, the dual-site
pacing is indicated for all patients with paroxysmal
atrial ﬁbrillation.50) It is considered that the patients
with atrial ﬁbrillation show abnormal dispersion of
the atrial refractory period.51) Josephson et al.52)
reported that the diﬀerence in the eﬀective refractory
period between the high right atrium and the ostium
of coronary sinus is 35ms in patients with atrial
ﬁbrillation and 5ms in those without atrial ﬁbrilla-
tion. A dispersion of refractory period is already
present in the atrium of the patients with atrial
ﬁbrillation. Additionally, it is said that the isthmus
between the tricuspid valve and Koch’s triangle is a
key zone for occurrence of arrhythmia in patients
with atrial ﬁbrillation and that the stimulation of the
ostium of coronary sinus not only reduces the
dispersion of refractory period but also improves
slow conduction and delayed conduction of the right
and left atria.53) According to the results of a
multicenter cooperative study, DAPPAP (dual atrial
site pacing for prevention of atrial ﬁbrillation),
performed on 120 patients with drug-resistant atrial
Figure 4 An example of dual-site pacing.
A coronary sinus lead was inserted into the mid cardiac vein to pace the surrounding of the ostium of coronary
sinus. The pacemaker used was Talent DR of Ela, Inc.
J Arrhythmia Vol 21 No 4 2005
442
ﬁbrillation, it has been reported that paroxysmal
atrial ﬁbrillation was completely inhibited in 55% of
the patients and that the clinical eﬀect in combina-
tion with drugs reached 80% to 90%.54) Figure 4
shows a chest X-ray from the patient continuing the
dual-site pacing over 2 years. In this patient,
although paroxysmal atrial ﬁbrillation could not be
inhibited completely, the number of attacks of atrial
ﬁbrillation and the duration of atrial ﬁbrillation was
markedly decreased, and ﬁnally symptoms of ar-
rhythmia disappeared by dual-site pacing.
5) Atrial septal pacing
When the right atrial appendage is paced electro-
physiologically, the conduction time to the left
atrium is prolonged compared with the time of sinus
rhythm, but when the high atrial septum is paced, the
same conduction time to the left atrium as that at
sinus rhythm is achieved. In addition, high degree
interatrial conduction delay between right and left
atria is associated with atrial reentrant tachyarryth-
mias.55,56) Bailin et al. therefore considered that the
pacing of the right atrial Bachmann’s bundle could
reduce the conduction time to the left atrium and
prevent atrial ﬁbrillation.57,58) Recently, a great
involvement of lone atrial premature contraction in
the onset of atrial ﬁbrillation has been noticed and
catheter ablation has been performed aggressively on
the surrounding of the focus and left superior
pulmonary vein, and relatively good results have
been reported.59) If it is important to inhibit atrial
premature contraction occurring from the surround-
ing of left superior pulmonary vein for prevention of
atrial ﬁbrillation, it is theoretically considered that
pacing of Bachmann’s bundle is more eﬀective than
the stimulation of left atrium by the bi-atrial pacing.
Until now, however, no clinical result showing that
pacing of Buchmann’s bundle is superior to multi-
site pacing has been reported. More recently, there
are some reports that lower septal pacing was more
eﬀective than conventional atrial pacing for AF
prevention.
6) Termination of AF
Pacing therapy for termination of AF has been
receiving increasing attention as a result of the
limited clinical eﬃcacy with antiarrhythmic drugs.
Also, nonpharmacological techniques for preventing
PAF have not been reported to be associated with a
complete elimination of PAF. Experimental studies
have shown that AF consist of microreentrant
wavelets propagating within the atrial tissue.60,61)
Similarly, patients with a history of AF have been
shown to exhibit altered characteristics of atrial
refractoriness.62) It is therefore vital to termination
soon after initiation of PAF. Allessie et al.63)
demonstrated that local atrial capture by pacing
was possible during AF. However, preliminary
results with single site atrial pacing have failed to
terminate chronic AF.64,65) Apparent success was
only reported in some cases of acutely induced
paroxysmal AF, but not in clinical cases.65) There-
fore, persistent AF cannot be terminated by rapid
single site atrial pacing at present time. Recently, a
relative large clinical trial, the AT 500 Veriﬁcation
Study, the AT 500 pacemaker associated with rapid
pacing program to terminate AF was compared to
conventional DDD pacemaker. The success rate
using by atrial tachcardia pacing (Burst pacing; 12%
and Ramp pacing 43%) was 54.7% and showed the
same eﬃcacy as conventional DDD pacemaker.66)
We can reasonably assume that in the near future
atrial Burst and Ramp pacing will have an important
role in the prevention of highly recurrent and drug-
resistant atrial ﬁbrillation. However, it is unlikely
that atrial Burst and Ramp pacing will ensure
complete and permanent protection. Therefore,
further technical improvements are necessary to
achieve the clinical eﬃcacy of atrial Burst and Ramp
pacing for AF.
7) Ventricular pacing intervention
Numerous reports have shown that AF are more
likely to occur with ventricular pacing than with
dual-chamber pacing. It has been suggested that AF
can be prevent by controlling the atrial rate. How-
ever, DVI pacing may be associated with a high
incidence of AF because of lacking AV synchrony
and competition with the spontaneous atrial
rhythm.67) Also, Benditt reported that DDD pacing
may not control the development of AF in patients
with frequent atrial tacharrhythmia.68) One of the
reason why DDD pacing could not be prevented AF
totally is that DDD pacing results in right ventricular
pacing. A number of studies have shown that right
ventricular pacing is detrimental to hemodynamics,
atrioventricular valve regurgitation and a higher
prevalence of AF. Sweeney reported that a signiﬁ-
cant increasing risk of AF has been documented
corresponding with right ventricular pacing up to
40% in DDDR mode.69) Patients implanted with
DDD pacemaker may therefore have a higher AF
burden if they are programmed to the short AV delay
than spontaneous AV conduction time. On the other
hand, ventricular rate instability could aﬀect the
recurrence of AF in some patients. If this is an
acceptable theory, stabilization of ventricular rate
during paroxysmal AF may prevent recurrence of AF
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and some studies have been developed. In these
studies ventricular rate stabilization (VRS) reduced
ventricular rate irregularity and improved Quality of
Life and exercise tolerance.70) However, there is no
evidence that VRS could be prevented the early
restarts of AF.
Preventative pacing algorithms
1) Overdrive pacing algorithms
Pacing algorithms for preventing AF have been
proposed for the suppression of atrial extrasystoles
by overdriving pacing. The role of this algorithm is
to reduce atrial premature contraction. It is believed
that atrial premature contraction will be reduced
following by increasing the heart rate. Mugatroyd et
al.71) reported that when an algorithm is used to
increase the heart rate to 12.5% higher than the
previous sinus rhythm at detection of atrial prema-
ture contraction by dissolving the resting phase after
premature contraction was obtained, atrial premature
contraction and the short run of atrial premature
contraction were reduced by 69% and 75%, respec-
tively. Unfortunately, no signiﬁcant reduction of
paroxysmal atrial ﬁbrillation could be achieved.
Only the patients frequently showing paroxysmal
atrial ﬁbrillation before the study, a signiﬁcant
decrease in the number of attacks was observed,
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Figure 5 A scheme of minimum incremen-
tal overdrive atrial pacing.
The pacemaker conducts atrial pacing at a
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aﬀect by the conﬁrmation of PAC or not.
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Figure 6 A scheme of algorithm for the elimination of short-long sequence.
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suggesting the usefulness of this algorithm. In
manual overdrive rate setting, the atrial rate is
constantly set to 10 or 15 beats faster than the
intrinsic heart rate at some detecting point. This
allows having a good percentage of pacing at rest but
not reacting during sympathetic over activity state
such an atrial arrhythmia or high emotional episodes.
The increase of atrial basic rate until 100 ppm is
acceptable and feasible for young patients without
distinct cardiac diseases, but majority of older
patients with or without cardiac disease do not
tolerate such high atrial rates. Therefore, pacing
algorithms have been developed to increase the
pacing rate after a sensed premature atrial contrac-
tion (PAC) and to reduce the pacing rate during no
atrial sensing (Figure 4). Despite high percentages of
atrial pacing because of automatic overdrive algo-
rithms, these algorithms do not increase the mean
heart rate signiﬁcantly and thus are well tolerated by
patients.72) One study showed a proportion of atrial
pacing with an automatic overdrive pacing algo-
rithms of 84% with a concomitant reduction of the
number and duration of mode switching episodes.73)
However, these overdriving algorithms achieved a
high atrial pacing rate and signiﬁcant reduction of
PACs but no signiﬁcant reduction in the AF burden
have been reported.74)
2) Elimination of short-long cycle
The purpose of this algorithm is to dissolve a
short-long sequence after premature atrial contrac-
tion and to allow smooth restoration of sinus rhythm.
The atrial rate stabilization to gradually make the
pacing rate slow considering the coupling interval as
the ﬁrst cycle at appearance of atrial premature
contraction and to return it to the sinus cycle before
occurrence of atrial premature contraction has been
examined. Several pacemaker companies have de-
veloped these algorithms to prevent AF. In Vitatron
BV, Post PAC Response, this have been designed
that a single pulse with a coupling interval equal to
the mean of the preceding beats (Figure 5) and Ela
Medical, Acceleration on PAC, also designed that
a pacing rate accelerate for a programmable time.
3) Prevention of early reinitiation of AF
The AF therapy study evaluated the phenomenon
of early reinitiation of AF (ERAF) and ERAF has
been attributed to the concept of atrial remodeling.
In Medtronic, Post Mode Switching Overdrive
Pacing, which increase the lower pacing rate for a
programmable time if the pacemaker cessation of
scanning time
rate
sinus rhythm pacing rhythm
DDDR DDIR DDDR
overdrive
mode switching
Figure 7 A scheme of preventive algo-
rithm for the early reinitiation of AF.
The pacemaker conducts overdrive pacing at
programmed intervention rate immediately after
cessation of automatic mode switching.
1.short duration
exercise
exercise
exercise
medium level
medium level
2. long duration
3. high level long
duration
1 2
3Rate
Pacing rate
Underlying pacing rate
Underlying atrial rhythm
Time
Sinus rhythm
Figure 8 A scheme of algorithm for the
prevention of sudden rate drop.
The algorithm has been designed to maintain a
higher pacing rate as soon as the rate drop was
detected by pacemaker after termination of
exercise.
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automatic mode switching, has been evaluated to
protect the ERAF (Figure 6). In addition with the
atrial rate stabilization algorithm, this preventive
pacing mode reduced the mean number of AT
episodes.75)
4) Post exercise rate control
It has been reported that AF can be easily induced
by sudden decrease of atrial rate in susceptible
patients.76) To prevent this AF triggering mecha-
nisms, Post-Exercise Response has been designed
to maintain a higher pacing rate as soon as the rate
drop was detected by pacemaker after termination of
exercise (Figure 7). Also, this algorithm is proposed
to prevent the ischemia by preventing a rapid rate
drop after exercise and keeping the balance between
the myocardial oxygen supply and demand. It is
because ischemia acts on the atrial muscle to aﬀect
the atrial substrate and contributes to the onset of
atrial ﬁbrillation.
Patient selection for preventive AF pacing
What type of patients will be indicated for pacing
therapy in the future? It is believed that almost AF
patients are indicated for catheter ablation. Indeed,
AF is often initiated by triggering with PAC from the
pulmonary veins and pulmonary veins isolation can
eﬀectively cure. However, these patients have some
speciﬁc characteristics such as: younger people, less
association with cardiac disease, drug-refractory, and
no bradycardia. Especially, in younger patients,
about 45% of paroxysmal AF and 25% of persistent
cases occur as lone AF.77) Recently, it was recog-
nized that there are diﬀerences in patients character-
istics between pacemaker and catheter ablation
patients. The characteristics in patients who will be
indicated preventing AF pacing are older people,
associated with bradycardia and cardiac disease, and
more co morbidities. In AF patients older than 70
years and who received coronary artery bypass
surgery, prevention by atrial pacing is particularly
useful,78,79) whereas beta-blocker therapy was found
to be of little beneﬁt in preventing postsurgical
AF.80) Another issue might be resolved is indication
for non-bradycardia patients. Unfortunately, there is
no evidence that strongly suggest the eﬃcacy of
preventive pacing in non-bradycardia patients, and
thereby these patients are not suitable for preventing
AF pacing. At the present time, deﬁnitely suitable
patients for preventing AF pacing are considered as
the patients with pacing indication for bradycardia
associate with paroxysmal AF and intended AV node
ablation. In addition, the patients with cardiac
resynchronization therapy and ICD implantation
are probably suitable for preventing AF pacing.
Conclusion
Novel Preventive Pacing oﬀer a new therapeutic
method for the prevention of atrial ﬁbrillation. These
therapeutic methods are safe and well tolerated and
reduces AF burden. Also, the preventive pacing may
eliminate the need for multiple drugs in many
patients or frequent cardioversion shock. However,
the success rate of preventing AF by pacing
technique is still low and it might need Hybrid
therapy such as pacing with ablation. Therefore, in
contrast to bradyarrhythmia, preventive pacing of
AF is still a new therapeutic method that needs
further improvement before it may be considered as
a ﬁrst-line therapy. A new pacing therapy for atrial
ﬁbrillation is expected, however, the pacing therapy
for prevention of atrial ﬁbrillation is quite diﬀerent
from the pacing therapy accompanying the conven-
tional treatment of bradycardia. In addition, it is not
fully eﬀective in all patients with paroxysmal atrial
ﬁbrillation. It is therefore necessary to decide the
indication after examining the mechanism and
trigger of the onset of individual atrial ﬁbrillation.
Furthermore, regarding technical aspect of multi-site
pacing, improving the procedure for lead insertion
into the coronary sinus and the method of tip
ﬁxation, and developing a new lead as well as the
shape of the lead for coronary sinus are a necessary
condition. Finally, it is essential to expand clinical
application to demonstrate the utility of a new pacing
therapy for atrial ﬁbrillation by a large-scale pro-
spective study.
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